Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism

American Journal of Hematology

Volumn 67, Issue 1, 2001, Pages 10-14

  Grau, Enric ^a   Tenias, Jose M ^a   Real, Esperanza ^a   Medrano, Jose ^a   Ferrer, Rosario ^a   Pastor, Emilio ^a   Selfa, Salvador ^a  

^a HOSPITAL LLUÍS ALCANYÍS   (Spain)

Author keywords

Deep venous thrombosis; Home treatment; Long term follow up; Low molecular weight heparin; Recurrent venous thromboembolism

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEPARINIZATION; HOME CARE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SURVIVAL; THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NADROPARIN; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0035060249     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.1069     Document Type: Article

References (19)

1. AHA medical/scientific statement. Special report. Guide to anticoagulant therapy. Pt. 2: Oral anticoagulants
2. Low-molecular-weight heparins
3. Antithrombotic therapy for venous thromboembolic disease
4. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
5. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
6. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis
7. Deep-vein thrombosis
8. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism
9. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
10. Home treatment of deep vein thrombosis: A two-years experience of a single institution
11. Recurrent venous thromboembolism in a Spanish population: Incidence, risk factors and management in a hospital setting
12. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin
13. Criteria for outpatient management of proximal lower extremity deep venous thrombosis
14. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis
15. Low molecular weight heparin
16. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis
17. Utility of impedance plethysmography in the diagnosis of recurrent deep-vein thrombosis
18. Long-term clinical follow-up in 265 patients with deep venous thrombosis initially treated with either unfractionated heparin or dalteparin: A retrospective analysis
19. The long-term clinical course of acute deep venous thrombosis